Cellular Reactivity toCandida albicansAntigen

Publisher Website
Google Scholar
Abstract
THE assessment of the integrity of delayed hypersensitivity reactions is frequently useful in certain clinical entities. An antigen that evokes a universally positive response in a normal population would consequently be most reliable for the detection of delayed skin unreactivity in patients with certain pathologic entities. Although Lewis and his associates1 described a 46 per cent incidence of delayed hypersensitivity to oidiomycin (Candida albicans antigen) in 192 healthy subjects, and Good et al.2 reported a 57 per cent incidence of delayed skin reactivity to C. albicans antigen in 208 hospitalized patients, we have found reactivity to this antigen to . . .